Publications by authors named "David T Rodgers"

Claim this Profile
S
Smart Cell Therapy: an industry perspective on macrophages as living drugs.
David T Rodgers, Tatiana Novobrantseva, Rita N Barcia

Cytotherapy· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of A Chimeric Antigen Receptor Targeting C-Type Lectin-Like Molecule-1 for Human Acute Myeloid Leukemia.
Eduardo Laborda, Magdalena Mazagova, Sida Shao, Xinxin Wang, Herlinda Quirino, David T Rodgers

Int J Mol Sci· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeted Delivery of an Anti-inflammatory PDE4 Inhibitor to Immune Cells via an Antibody-drug Conjugate.
Shan Yu, Aaron D Pearson, Reyna Kv Lim, David T Rodgers, Sijia Li

Mol Ther· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The helminth product, ES-62 modulates dendritic cell responses by inducing the selective autophagolysosomal degradation of TLR-transducers, as exemplified by PKCδ.
Russell J Eason, Kara S Bell, Fraser A Marshall, David T Rodgers, Miguel A Pineda

Sci Rep· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design of Switchable Chimeric Antigen Receptor T Cells Targeting Breast Cancer.
Yu Cao, David T Rodgers, Juanjuan Du, Insha Ahmad, Eric N Hampton

Angew Chem Int Ed Engl· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Versatile strategy for controlling the specificity and activity of engineered T cells.
Jennifer S Y Ma, Ji Young Kim, Stephanie A Kazane, Sei-Hyun Choi, Hwa Young Yun, David T Rodgers

Proc Natl Acad Sci U S A· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Switch-mediated activation and retargeting of CAR-T cells for B-cell malignancies.
David T Rodgers, Magdalena Mazagova, Eric N Hampton, Yu Cao, Nitya S Ramadoss

Proc Natl Acad Sci U S A· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Protective effect of small molecule analogues of the Acanthocheilonema viteae secreted product ES-62 on oxazolone-induced ear inflammation.
Lamyaa Al-Riyami, David T Rodgers, Justyna Rzepecka, Miguel A Pineda, Colin J Suckling

Exp Parasitol· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prophylactic and therapeutic treatment with a synthetic analogue of a parasitic worm product prevents experimental arthritis and inhibits IL-1β production via NRF2-mediated counter-regulation of the inflammasome.
Justyna Rzepecka, Miguel A Pineda, Lamyaa Al-Riyami, David T Rodgers, Judith K Huggan

J Autoimmun· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The parasitic worm product ES-62 targets myeloid differentiation factor 88-dependent effector mechanisms to suppress antinuclear antibody production and proteinuria in MRL/lpr mice.
David T Rodgers, Mairi A McGrath, Miguel A Pineda, Lamyaa Al-Riyami, Justyna Rzepecka

Arthritis Rheumatol· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An anti-B cell maturation antigen bispecific antibody for multiple myeloma.
Nitya S Ramadoss, Andrew D Schulman, Sei-hyun Choi, David T Rodgers, Stephanie A Kazane

J Am Chem Soc· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
ES-62 protects against collagen-induced arthritis by resetting interleukin-22 toward resolution of inflammation in the joints.
Miguel A Pineda, David T Rodgers, Lamyaa Al-Riyami, William Harnett, Margaret M Harnett

Arthritis Rheumatol· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Protection against collagen-induced arthritis in mice afforded by the parasitic worm product, ES-62, is associated with restoration of the levels of interleukin-10-producing B cells and reduced plasma cell infiltration of the joints.
David T Rodgers, Miguel A Pineda, Mairi A McGrath, Lamyaa Al-Riyami, William Harnett

Immunology· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Designing anti-inflammatory drugs from parasitic worms: a synthetic small molecule analogue of the Acanthocheilonema viteae product ES-62 prevents development of collagen-induced arthritis.
Lamyaa Al-Riyami, Miguel A Pineda, Justyna Rzepecka, Judith K Huggan, Abedawn I Khalaf, David T Rodgers

J Med Chem· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis